The sandwich shop has confidentially filed for an IPO, even as fast-food and sit-down chains are stuck in a discount war to win over inflation-fatigued consumers.
Investors found value in low-rated loans; biotech startup acquisitions jumped in 2020, and Michelin-star eateries in England offered feasts to go to please wealthy clients.
